Literature DB >> 19935408

Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depression.

Hiroshi Hayashi1, Takaki Akahane, Haruyoshi Suzuki, Tetsuya Sasaki, Shinobu Kawakatsu, Koichi Otani.   

Abstract

The case of a 42-year-old woman with delusional disorder, somatic type (DDST), with infestation delusion and delusions of body odor and halitosis accompanied by severe secondary depression is presented. These somatic delusions and depressive symptoms responded favorably to treatment with paroxetine 10 to 30 mg/d. Hypoperfusion in the left temporal and parietal lobes observed when she had marked clinical symptoms was improved at near recovery. The present report suggests that paroxetine is effective and a reasonable drug for DDST with secondary depression. It also supports previous observations that DDST is associated with hypoperfusion in the temporal and parietal lobes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19935408     DOI: 10.1097/WNF.0b013e3181c1cfe4

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  4 in total

Review 1.  Differences between delusional disorder and schizophrenia: A mini narrative review.

Authors:  Alexandre González-Rodríguez; Mary V Seeman
Journal:  World J Psychiatry       Date:  2022-05-19

2.  Hypochondriacal delusion in an elderly woman recovers quickly with electroconvulsive therapy.

Authors:  Annemieke Dols; Didi Rhebergen; Piet Eikelenboom; Max L Stek
Journal:  Clin Pract       Date:  2012-01-18

Review 3.  Reframing delusional infestation: perspectives on unresolved puzzles.

Authors:  Jianbo Lai; Zhe Xu; Yi Xu; Shaohua Hu
Journal:  Psychol Res Behav Manag       Date:  2018-10-01

Review 4.  Moderators and mediators of antipsychotic response in delusional disorder: Further steps are needed.

Authors:  Alexandre González-Rodríguez; Armand Guàrdia; Diego José Palao; Javier Labad; Mary V Seeman
Journal:  World J Psychiatry       Date:  2020-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.